Offstream
news

The U.S. FDA and the CDC approve fourth doses of the Pfizer and Moderna COVID-19 vaccines for people over the age of 50 years.
2022-03-29

The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.
2022-01-3

The Food and Drug Administration authorizes the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11, becoming the first vaccine to be approved for children in the United States.
2021-10-29

The Food and Drug Administration officially authorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine as a booster shot for individuals still considered vulnerable to COVID-19. Among those eligible are health care workers and senior citizens who have been fully inoculated with the vaccine for at least six months.
2021-09-22

The Pentagon announces that COVID-19 vaccinations will be mandatory for the U.S. military after the FDA approved the vaccine developed by Pfizer and BioNTech.
2021-08-25

The Food and Drug Administration gives full approval to the Pfizer–BioNTech COVID-19 vaccine, becoming the first vaccine in the U.S. to be granted full licensure and thereby giving businesses, schools and universities more confidence to adopt vaccine mandates.
2021-08-23

The U.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people.
2021-08-12

The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months.
2021-07-16

The FDA announces its approval for measures allowing the Pfizer–BioNTech COVID-19 vaccine to be stored at regular refrigerator temperatures for up to 30 days before administration. Previously, the agency had only allowed such storage for five days.
2021-05-20

The Food and Drug Administration authorizes the Pfizer–BioNTech vaccine for use in children between the ages of 12 and 15 years.
2021-05-10